AmpliPhi Biosciences Corporation - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "AmpliPhi Biosciences Corporation - Product Pipeline Review - 2014" provides data on the AmpliPhi Biosciences Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, AmpliPhi Biosciences Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from AmpliPhi Biosciences Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- AmpliPhi Biosciences Corporation - Brief AmpliPhi Biosciences Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AmpliPhi Biosciences Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AmpliPhi Biosciences Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AmpliPhi Biosciences Corporation's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate AmpliPhi Biosciences Corporation's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AmpliPhi Biosciences Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AmpliPhi Biosciences Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AmpliPhi Biosciences Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AmpliPhi Biosciences Corporation and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
AmpliPhi Biosciences Corporation Snapshot 5
AmpliPhi Biosciences Corporation Overview 5
Key Information 5
Key Facts 5
AmpliPhi Biosciences Corporation - Research and Development Overview 6
Key Therapeutic Areas 6
AmpliPhi Biosciences Corporation - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
AmpliPhi Biosciences Corporation - Pipeline Products Glance 15
AmpliPhi Biosciences Corporation - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
AmpliPhi Biosciences Corporation - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
AmpliPhi Biosciences Corporation - Drug Profiles 19
BioPhage-PA 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
tgAAG76 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AmpliPhage-002 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
BioPhage-PR 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Drug For Acinetobacter Baumanii 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Drug For Clostridium Difficile Infection 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AmpliPhi Biosciences Corporation - Pipeline Analysis 25
AmpliPhi Biosciences Corporation - Pipeline Products by Therapeutic Class 25
AmpliPhi Biosciences Corporation - Pipeline Products by Target 26
AmpliPhi Biosciences Corporation - Pipeline Products by Route of Administration 27
AmpliPhi Biosciences Corporation - Pipeline Products by Molecule Type 28
AmpliPhi Biosciences Corporation - Pipeline Products by Mechanism of Action 29
AmpliPhi Biosciences Corporation - Recent Pipeline Updates 30
AmpliPhi Biosciences Corporation - Dormant Projects 31
AmpliPhi Biosciences Corporation - Discontinued Pipeline Products 32
Discontinued Pipeline Product Profiles 32
tg-AAVCF 32
tgAAC-94 32
AmpliPhi Biosciences Corporation - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35

List of Tables
AmpliPhi Biosciences Corporation, Key Information 5
AmpliPhi Biosciences Corporation, Key Facts 5
AmpliPhi Biosciences Corporation - Pipeline by Indication, 2014 8
AmpliPhi Biosciences Corporation - Pipeline by Stage of Development, 2014 9
AmpliPhi Biosciences Corporation - Monotherapy Products in Pipeline, 2014 10
AmpliPhi Biosciences Corporation - Partnered Products in Pipeline, 2014 11
AmpliPhi Biosciences Corporation - Partnered Products/ Combination Treatment Modalities, 2014 12
AmpliPhi Biosciences Corporation - Out-Licensed Products in Pipeline, 2014 13
AmpliPhi Biosciences Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2014 14
AmpliPhi Biosciences Corporation - Phase II, 2014 15
AmpliPhi Biosciences Corporation - Phase I, 2014 16
AmpliPhi Biosciences Corporation - Preclinical, 2014 17
AmpliPhi Biosciences Corporation - Discovery, 2014 18
AmpliPhi Biosciences Corporation - Pipeline by Therapeutic Class, 2014 25
AmpliPhi Biosciences Corporation - Pipeline by Target, 2014 26
AmpliPhi Biosciences Corporation - Pipeline by Route of Administration, 2014 27
AmpliPhi Biosciences Corporation - Pipeline by Molecule Type, 2014 28
AmpliPhi Biosciences Corporation - Pipeline Products by Mechanism of Action, 2014 29
AmpliPhi Biosciences Corporation - Recent Pipeline Updates, 2014 30
AmpliPhi Biosciences Corporation - Dormant Developmental Projects,2014 31
AmpliPhi Biosciences Corporation - Discontinued Pipeline Products, 2014 32
AmpliPhi Biosciences Corporation, Other Locations 33